Monday, September 21, 2015

Cardiac Implants Devices Market Expected to Grow at a CAGR of 12.5% by 2020.

Cardiac Implants and Monitoring Devices are used for not only improving the lifestyle but also extending the lifespan of millions of people worldwide. By engineering modifications, the latest changes in the last 40 years have revolutionized the treatment of cardiac diseases. Cardiac Implants and Monitoring Devices have drastically improved early diagnosis, treatment and epidemiology of various heart diseases and congenital heart ailments.

Request for Sample Data / Brochure:
http://industryarc.com/pdfdownload.php?id=2332

Cardiac disease is a group of disorders of blood vessels and heart. Congenital heart defects, coronary artery disease and heart rhythm problems are some of the major cardiac diseases. Most common cause of heart disease is narrowing or blockage of blood vessels and coronary artery i.e. ischemic heart disease. Cardiac disease is mainly caused due to high cholesterol, smoking and high blood pressure. In addition, several other diseases such as, diabetes and obesity, and lifestyle changes such as poor nutrition, excessive alcohol and physical inactivity causes higher risk of cardiac diseases. In the U.S., heart disease is the leading cause of death in men and women. Thus this region becomes a strong market area for the Cardiac Implant Devices Market.


Market Trends & Growth:
According to IndustryARC, the Cardiac Implants Devices Market will grow significantly in the coming 5 years and projected to reach $43.4 Billion by 2020 rising at a CAGR of 12.5%. Considering the market being $21.4 Billion in 2014, the current growth estimation seems hopeful for the investors.
Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), atrial fibrillation and aortic aneurysms and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the Key Drivers for the growth of this market.
Segment wise, coronary stents devices are generating the largest revenue whereas in future TAVR (Transcatheter Aortic Valve Replacement) valves are expected to capture the major market segment.
Regionally, Americas and Europe were noted to have occupied a substantial market share of 60% and 22% respectively. It can be observed that Asia-Pacific is growing higher rate as compared to developed countries but generating lesser revenues due to detrimental factors like cost and reimbursement policies.


REPORT SCOPE: Market Segmentation:
The Cardiac Implant Devices Market is segmented into broad 4 types based on the factors:
  1. By Devices: Cardiac Resynchronization Therapy Devices (CRT’S),  Implantable Cardioverter Defibrillators (ICD’S), Implantable Cardiac Pacemakers (ICPs) and Others.
  2. By Disease Conditions: Myocardial Ischemia, Acute Myocardial Infarction, Arrhythmias and Others.
  3. By Procedure: Cardiac Resynchronization Therapy (CRT), Minimally Invasive Heart Surgery and Others.
  4. By Geography: North America, Europe, APAC and ROW.

Key Players:
Few notable competitors of this market which are mentioned in this report are:
  • Abbott Vascular Inc.
  • Bentley InnoMed GmbH
  • Medtronic, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Alvimedica


Related Reports You May Be Interested:
Wearable Medical Devices Market By Type (Therapeutic Wearable Devices, Diagnostic Devices, Vital Sign Monitoring Devices, Activity Monitors, Electrocardiographs and Others); By Application (Home Health Care, Remote Patient Monitoring, Fitness And Sports and Others) and By Geography - Forecast (2015-2020)
http://industryarc.com/Report/205/Wearable-medical-devices-Market-Analysis-Report.html
                                                                                   

For More Details Contact:
Mr. Sanjay Matthews
Sales Manager
Contact Sales: 1-614-588-8538 (Ext-101)

No comments:

Post a Comment